The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...

Cervical cancer has historically been a significant public health issue worldwide, causing substantial morbidity and mortality among women. Over recent decades, advances in screening, vaccination, and ...

Please provide your email address to receive an email when new articles are posted on . Lack of a primary care provider may hinder an individual’s ability to undergo lung cancer screening, according ...

Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a new ...